CLINICAL CHARACTERISTICS AND LABORATORY FEATURES OF DENGUE IN HOSPITALIZED OLDER ADULTS
Main Article Content
Abstract
Objective: To describe the clinical and laboratory characteristics of older adults with dengue and to explore factors associated with disease severity.
Methods: A prospective observational longitudinal study was conducted on 444 hospitalized patients with dengue at the National Hospital for Tropical Diseases, Vietnam, during 2024-2025. Patients were categorized into two age groups: <60 years (n=217) and ≥ 60 years (n=227). Collected variables included baseline characteristics, clinical manifestations at admission, laboratory parameters (platelet count and AST), and selected treatment interventions. Comparisons between groups were performed using appropriate statistical tests with a significance level of p<0.05.
Results: Older adults had significantly higher rates of comorbidities, particularly hypertension (38.8%) and diabetes (21.1%). The proportion of high fever (≥ 39°C) was lower in the ≥ 60 group compared with the younger group (4.4% vs 19.4%). Platelet counts were markedly lower in older adults both at admission (30.0 vs 92.0 G/L) and at nadir during hospitalization (15.0 vs 42.0 G/L; p<0.001). Elevated AST levels, platelet transfusion, and antibiotic use were more frequent among older adults.
Conclusion: Older adults with dengue tend to present with less typical clinical manifestations but demonstrate more pronounced thrombocytopenia and liver enzyme elevation. Close monitoring of laboratory parameters, particularly platelet count and AST, is important for assessing disease severity in this population.
Keywords
Dengue, older adults, clinical characteristics, thrombocytopenia, disease severity
Article Details
References
2. Annan E, Treviño J, et al. Direct and indirect effects of age on dengue severity: the mediating role of secondary infection. PLoS Negl.Trop. Dis. 2023;17:e0011537.
3. Hökerberg YHM, Kohn F, et al. Clinical profile of dengue in the elderly using surveillance data from two epidemics. Rev. Soc. Bras. Med. Trop. 2022;55:e0290-2021.
4. Jeng M-J, Lee N-Y, et al. Prognosis and mortality risk in elderly patients with dengue virus infection: excess fatality and the urgent need for revising current WHO criteria for elderly patients. Travel Med. Infect. Dis. 2025;65:102855.
5. Vuong NL, Quyen NTH, et al. Dengue viremia kinetics and effects on platelet count and clinical outcomes: An analysis of 2340 patients from Vietnam. eLife. 2024;13:RP92606.
6. Anh DD, The NT, et al. Epidemiology and genotype dynamics of dengue in hospitalized patients in northern Vietnam between 2020 and 2022. Open Forum Infect. Dis. 2025;12:ofae753.
7. Anh DD, Vugrek L, et al. Characterization of dengue patients in Vietnam: clinical, virological, and IL-10 profiles during 2021- 2022 outbreaks. PLoS Negl.Trop. Dis. 2025;19:e0012954.
8. Taylor WR, Fox A, et al. Dengue in adults admitted to a referral hospital in Hanoi, vietnam. Am. J. Trop. Med. Hyg. 2015;92:1141-1149.